SK217292A3 - Vaccine containing a pc protein useful in prevention of lyme disease, method of b.burgdorferi protein purification, diagnostic agent detecting b.burgdorferi antigens and method of detecting b.burgdorferi antigenes in humoralis - Google Patents

Vaccine containing a pc protein useful in prevention of lyme disease, method of b.burgdorferi protein purification, diagnostic agent detecting b.burgdorferi antigens and method of detecting b.burgdorferi antigenes in humoralis Download PDF

Info

Publication number
SK217292A3
SK217292A3 SK2172-92A SK217292A SK217292A3 SK 217292 A3 SK217292 A3 SK 217292A3 SK 217292 A SK217292 A SK 217292A SK 217292 A3 SK217292 A3 SK 217292A3
Authority
SK
Slovakia
Prior art keywords
protein
burgdorferi
vaccine
detecting
antigens
Prior art date
Application number
SK2172-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK279250B6 (sk
Inventor
Livey Ian
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK217292(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of SK279250B6 publication Critical patent/SK279250B6/sk
Publication of SK217292A3 publication Critical patent/SK217292A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK2172-92A 1991-07-11 1992-07-10 Vaccine containing a pc protein useful in prevention of lyme disease, method of b.burgdorferi protein purification, diagnostic agent detecting b.burgdorferi antigens and method of detecting b.burgdorferi antigenes in humoralis SK217292A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72724591A 1991-07-11 1991-07-11
US82416192A 1992-01-22 1992-01-22
US07/903,580 US6221363B1 (en) 1991-07-11 1992-06-25 Vaccine for the prevention of lyme disease

Publications (2)

Publication Number Publication Date
SK279250B6 SK279250B6 (sk) 1998-08-05
SK217292A3 true SK217292A3 (en) 1998-08-05

Family

ID=27419096

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2172-92A SK217292A3 (en) 1991-07-11 1992-07-10 Vaccine containing a pc protein useful in prevention of lyme disease, method of b.burgdorferi protein purification, diagnostic agent detecting b.burgdorferi antigens and method of detecting b.burgdorferi antigenes in humoralis

Country Status (17)

Country Link
US (2) US6221363B1 (es)
EP (1) EP0522560B2 (es)
JP (1) JP2611095B2 (es)
AT (1) ATE198489T1 (es)
AU (1) AU660178B2 (es)
CA (1) CA2073486C (es)
CZ (1) CZ280743B6 (es)
DE (1) DE69231619T3 (es)
DK (1) DK0522560T4 (es)
ES (1) ES2154633T3 (es)
FI (1) FI107334B (es)
HR (1) HRP950174B1 (es)
HU (1) HU219772B (es)
MX (1) MX9204078A (es)
NO (1) NO304546B1 (es)
SI (1) SI9200143B (es)
SK (1) SK217292A3 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872550B1 (en) * 1991-07-11 2005-03-29 Baxter Vaccine Ag Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
US6303129B1 (en) * 1992-07-28 2001-10-16 Rx Technologies Production of borrelia burgdorferi vaccine, product produced thereby and method of use
PL178775B1 (pl) * 1993-04-29 2000-06-30 Baxter Ag Kompozycja immunogenna, rekombinacyjne sekwencje DNA, rekombinacyjny wektor ekspresyjny, transformowana komórka gospodarza i antygen OspC
US6248562B1 (en) 1993-11-01 2001-06-19 Research Foundation State University Of New York Chimeric proteins comprising borrelia polypeptides and uses therefor
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
PT757556E (pt) 1994-04-11 2006-10-31 Wyeth Corp Bacterina borrelia burgdorferi
US6087097A (en) * 1994-05-12 2000-07-11 Mayo Foundation For Medical Education And Research PCR detection of Borrelia burgdorferi
ZA964896B (en) * 1995-06-07 1997-01-08 Connaught Lab Expression of lipoproteins
CN1285608C (zh) * 1995-09-22 2006-11-22 康诺特实验室有限公司 副流感病毒糖蛋白和疫苗
WO1997015600A1 (en) * 1995-10-26 1997-05-01 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Tick (ixodes scapularis) vector saliva-induced lyme disease spirochete (borrelia burgdorferi) antigens as vaccine candidates
US6045804A (en) * 1996-03-07 2000-04-04 Mayo Foundation For Medical Educational Research Method for detecting B. burgdorferi infection
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
GB9811219D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel process
EP1173577A2 (en) * 1999-04-21 2002-01-23 Boston Medical Center Corporation Prevention, diagnosis and treatment of lyme disease
PT1194559E (pt) * 1999-06-18 2007-01-31 Brook Biotechnologies Inc Grupos de borrelia burgdorferi e borrelia afzelii que causam a doença de lyme em seres humanos
WO2002016421A2 (en) 2000-08-18 2002-02-28 Research Foundation Of The State University Of New York Altered ospa of borrelia burgdorferi
US8277852B2 (en) * 2002-01-25 2012-10-02 Akzo Nobel Surface Chemistry Llc Bioactive botanical cosmetic compositions and processes for their production
US7442391B2 (en) * 2002-01-25 2008-10-28 Integrated Botanical Technologies, Llc Bioactive botanical cosmetic compositions and processes for their production
ES2652603T3 (es) 2004-01-12 2018-02-05 Isp Investments Llc Composiciones bioactivas de plantas de Theacea y procedimientos para su producción y uso
EP1983247A1 (en) 2006-01-19 2008-10-22 Toyo Seikan Kaisya, Ltd. Coupler and fuel cartridge for fuel cell
EP2077856B1 (en) * 2006-11-03 2015-08-12 Intervet International BV Canine lyme disease vaccine
ATE496935T1 (de) 2007-02-22 2011-02-15 Baxter Int Verfahren zur aufreinigung hydrophober proteine
JP2011518338A (ja) * 2008-04-22 2011-06-23 リサーチ ファンデーション オブ ステート ユニバーシティ オブ ニューヨーク ボレリア・ブルグドルフェリ(borreliaburgdorferi)の細胞エンベロープタンパク質のアレイ
CN102791727A (zh) * 2009-11-17 2012-11-21 爱贝斯股份有限公司 用于检测莱姆病抗体的肽和方法
DK3549949T5 (da) 2011-04-22 2024-09-02 Wyeth Llc Sammensætninger vedrørende et mutant Clostridium-difficile-toksin og fremgangsmåder dertil
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
KR102451333B1 (ko) * 2018-10-22 2022-10-06 주식회사 엘지화학 마이크로비드 및 그 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
US4601903A (en) * 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
US4888276A (en) 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US5192540A (en) * 1988-04-19 1993-03-09 American Cyanamid Company Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine
DE3818013A1 (de) 1988-05-27 1989-11-30 Henkel Kgaa Gewebeweichmachungsmittel
IT1223777B (it) * 1988-08-18 1990-09-29 Gevipi Ag Rubinetto a due uscite con inversore a depressione
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
DE3942728C1 (en) 1989-12-22 1991-05-23 Mikrogen Molekularbiologische Entwicklungs-Gmbh, 8000 Muenchen, De New immunologically active proteins derived from Borelia burgdorferiensity polyethylene vessel and a high density polyethylene sealing cap - useful as vaccine and for quick accurate diagnosis of Borelia infections
CA2072008C (en) * 1989-12-22 2003-01-28 Renate Fuchs Immunologically active proteins from borrelia burgdorferi, related test kits which contain these proteins and are suitable for detecting antibodies in test fluids, and the use of these proteins as vaccines against infections caused by borrelia strains
DE69122240T2 (de) 1990-03-05 1997-02-13 The United States of America, represented by the Secretary, U.S. Department of Commerce, Washington, D.C. Antigen-wirkende proteine von borrelia burgdorferi
EP1016416A3 (en) * 1990-07-06 2002-10-23 Wyeth Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy

Also Published As

Publication number Publication date
SK279250B6 (sk) 1998-08-05
AU660178B2 (en) 1995-06-15
US6221363B1 (en) 2001-04-24
FI923175A (fi) 1993-01-12
EP0522560A3 (en) 1994-05-11
DE69231619T3 (de) 2007-07-12
ES2154633T3 (es) 2001-04-16
HRP950174B1 (en) 2001-08-31
JP2611095B2 (ja) 1997-05-21
EP0522560B2 (en) 2006-12-20
AU1934992A (en) 1993-01-14
EP0522560B1 (en) 2001-01-03
FI923175A0 (fi) 1992-07-09
NO922746D0 (no) 1992-07-10
CA2073486A1 (en) 1993-01-12
EP0522560A2 (en) 1993-01-13
US5530103A (en) 1996-06-25
ATE198489T1 (de) 2001-01-15
DE69231619T2 (de) 2001-05-31
HRP950174A2 (en) 1997-08-31
SI9200143B (en) 2001-06-30
CZ217292A3 (en) 1993-01-13
HUT66525A (en) 1994-12-28
NO304546B1 (no) 1999-01-11
DE69231619D1 (de) 2001-02-08
CZ280743B6 (cs) 1996-04-17
JPH072696A (ja) 1995-01-06
HU219772B (hu) 2001-07-30
NO922746L (no) 1993-01-12
DK0522560T3 (da) 2001-03-05
HU9202289D0 (en) 1992-10-28
DK0522560T4 (da) 2007-04-10
SI9200143A (en) 1993-03-31
FI107334B (fi) 2001-07-13
MX9204078A (es) 1993-04-01
CA2073486C (en) 2002-07-02

Similar Documents

Publication Publication Date Title
SK217292A3 (en) Vaccine containing a pc protein useful in prevention of lyme disease, method of b.burgdorferi protein purification, diagnostic agent detecting b.burgdorferi antigens and method of detecting b.burgdorferi antigenes in humoralis
US5747294A (en) Compositions and methods for the prevention and diagnosis of lyme disease
Akins et al. Lipid modification of the 17-kilodalton membrane immunogen of Treponema pallidum determines macrophage activation as well as amphiphilicity
EP0445135A1 (en) BORRELIA BURGDORFERI FRACTIONS WITH IMMUNOGENIC ACTION.
US5656451A (en) OspE, OspF, and S1 polypeptides in borrelia burgdorferi
CZ289212B6 (cs) Imunogenní prostředek proti lymskému onemocnění, sekvence rekombinantní DNA, OspC antigen, pouľití kombinace antigenů a způsob rekombinantní výroby OspC antigenu
EP0617128A1 (en) Recombinant vaccine for porcine pleuropneumonia
Champion et al. Sequence analysis and recombinant expression of a 28-kilodalton Treponema pallidum subsp. pallidum rare outer membrane protein (Tromp2)
ES2203704T3 (es) Proteinas de membrana de leptospira.
US5549898A (en) Immunogenic anaplasma marginale surface antigens, compositions, and methods of use
RU2102081C1 (ru) Иммуногенная композиция против боррелиоза лайма, способ иммунизации млекопитающего против боррелиоза лайма, способ получения белка pc borrelia burgdorferi, диагностический агент для обнаружения b.burgdorferi и способ обнаружения антител к b.burgdorferi
US6716591B1 (en) B. burgdorferi polypeptides
US20030124567A1 (en) Use of a leptospire protein preventing and/or diagnosing and/or treating animal or human leptospirosis
WO1997042325A1 (en) B. burgdorferi polypeptides expressed in vivo
against Infection Active and Passive Immunity against
WO2001070252A1 (en) Novel borrelia burgdorferi polypeptides and uses thereof
MXPA97001224A (es) Vacunas contra borrelia burgdorferi ospg
CA2281913A1 (en) A vaccine against piscirickettsia salmonis based on a recombinant 17 kd protein